LGND
Ligand Pharmaceuticals (LGND) Investor Questions
Review Ligand Pharmaceuticals (LGND) faq with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Company
- Ligand Pharmaceuticals
- Sector
- Healthcare
- Industry
- Biotechnology
- Overall BTI score
- 92
- Annual revenue
- $268.09M
- Annual net income
- $124.45M
- Annual free cash flow
- $48.91M
Ligand Pharmaceuticals (LGND) Investor Questions research
Ligand Pharmaceuticals trades under the ticker LGND. The company is classified in the Healthcare sector and the Biotechnology industry.
Investors commonly review LGND through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.